growth stocks

Are FANG Investors Playing the Role of Greater Fools? Analyze Out Loud Analysis of Facebook, Amazon, Netflix and Google

2018-08-14

Research Articles

Introduction The greater fool theory is an investing metaphor that suggests that if you pay more for a stock than it is worth (intrinsic value indicates) that you are only doing this on the basis that a fool greater than you will come along and willingly pay you more.  When you think about it, the […]

Peter Lynch Taught Me to Invest in Ultra Beauty Inc.

2018-01-31

Research Articles

Introduction In his best-selling book “One up on Wall Street” Peter Lynch included this subtitle on his cover: “How to use what you already know to make money in the stock market.”  And later in the book he talks about “the power of common knowledge.”  Stating it over simplistically, Peter Lynch often talked about getting […]

Searching for Alphabet’s True Worth? Should we Google it?

2017-08-30

Research Articles

Introduction This is the third in a series of articles where I will cover popular and/or high profile stocks. The primary objective of this series will be to put a spotlight on the importance of forecasting future growth prior to making an investment decision.  I elaborated on the importance of forecasting future growth in part […]

Priceline: A Growth Powerhouse – Forecast Profits and/or Cash Flow Not Prices!

2017-08-24

Research Articles

Introduction This is the second in a series of articles where I will cover popular and/or high profile stocks. The primary objective of this series will be to put a spotlight on the importance of forecasting future growth prior to making an investment decision. The central idea is to determine whether or not a reasonable […]

Pfizer Inc. Invest For Attractive Valuation and The 4% Dividend Yield

2017-02-22

Research Articles

Investment Thesis Pfizer Inc (PFE) is one of the world’s largest pharmaceutical firms with sales exceeding $50 billion.  The company is currently attractively valued at a blended P/E ratio of 13.3, offering a current dividend yield of 4%.  Pfizer is awarded an S&P credit rating of AA and possesses a modest debt to capital ratio […]

Broadcom, Limited: Exceptional Growth at a Reasonable Price-With A Dividend Kicker

2017-02-03

Research Articles

Investment Thesis Broadcom Limited (AVGO) has historically been, and is expected to continue to be a growth stock.  On the other hand, the company is also an attractive dividend growth stock as well.  The combination of high growth and above-average dividend yield is rare.  This becomes especially intriguing when you consider that their cash flow […]

Disclaimers: F.A.S.T. Graphs, Inc. is not a broker-dealer or a registered investment adviser. Under no circumstances does any information on Fastgraphs.com constitute a recommendation to buy or sell a security, nor does it give investment advice. This is to include any publications or articles on Fastgraphs.com. Fastgraphs.com is a research tool to be used by its subscribers in conjunction with the subscribers’ additional research and due diligence. The information on this site is in no way guaranteed for completeness or accuracy.